Data Characteristics for this Category
siRNA nucleic acid drug registration dossier data primarily originates from clinical trial reports, non-clinical study reports, manufacturing process and quality control documents, and regulatory guidelines. This data has a relatively low update frequency, with new versions typically released as research and development progresses and regulatory requirements evolve. Document structures are highly standardized, adhering to international standards such as ICH M4E, and organized in CTD (Common Technical Document) format, encompassing Modules 1 to 5. Data fields are complex and highly specialized, involving target genes, nucleotide sequences, modification types, delivery systems, pharmacokinetic parameters, pharmacodynamic indicators, and toxicology data. Units are strictly standardized, for example, molar concentration (nM), dosage (mg/kg), time (h), and percentage (%).
Constraints on Model Integration and Configuration
The standardized document structure and specialized fields of siRNA nucleic acid drug dossiers require models to accurately identify and parse CTD modules and sub-modules during data preprocessing, preventing information loss. The low update frequency makes historical version management and incremental update strategies crucial for knowledge base construction, ensuring knowledge timeliness. Highly specialized fields and strict units demand strong contextual understanding and accurate answer generation from models, particularly when dealing with critical parameters like dosage and concentration, requiring robust entity recognition and relationship extraction capabilities. Furthermore, given the potential inclusion of sensitive sequence information, data anonymization and access control must be considered during model integration.
Configuration Recommendations
| Configuration Item | Recommended Value | Rationale |
|---|---|---|
maxContext | 4096 tokens | Ensures critical information from long documents is not truncated while balancing inference efficiency. |
Chunk size | 800–1200 characters | Accommodates the paragraph length of siRNA nucleic acid drug documents, ensuring contextual completeness. |
Recall count | Top 5–8 entries | Balances recall precision with model processing burden, covering core knowledge points. |
Similarity threshold | 0.75–0.85 | Improves the quality of relevant recalls, reducing interference from irrelevant information. |
Rerank result count | 3 entries | Further refines recall results, providing the most relevant information to the model. |
UPLOAD_FILE_MAX_SIZE | 100 MB | Handles potentially large PDF or Word documents within CTD modules. |
Common Pitfalls
- Issue: Draft submission documents generated by the model are missing key pharmacokinetic parameters (e.g.,
t1/2) or have incorrect units. Reason: The knowledge base chunking strategy is too aggressive, leading to sentences containing critical numerical values and units being split, preventing the model from acquiring complete information. - Issue: When calling a vision model to parse charts in submission documents, the results are empty or the chart content is not recognized. Reason: The vision model API configuration is incorrect, or the chart data type (e.g.,
image/png) is not correctly passed, preventing the model from effectively processing non-textual information. - Issue: The model generates inaccurate or incomplete information when answering questions about siRNA sequences or modification types. Reason: The knowledge base index does not adequately account for the special characters and structure of siRNA sequences, leading to imprecise sequence matching during RAG recall.
Validation Steps
- Select typical questions from specific CTD modules (e.g., Module 2.7 Nonclinical Written and Tabulated Summaries) and observe if the model can accurately extract and integrate key data, such as drug mechanism of action, main toxic effects, and dose ranges. Verify that the output includes correct units.
- Upload submission documents containing complex charts (e.g., PK/PD curves) to test if the model can parse chart data via the vision model API. Based on the parsed results, assess if the model can answer related questions, confirming the effectiveness of vision model integration and data transfer mechanisms.
- Input queries related to siRNA nucleic acid drug sequence information or chemical structures. Verify if the model can accurately present nucleotide sequences, modification sites, and types in the output. Compare the output with the original documents to confirm sequence retrieval and generation quality.
The values provided are common starting points and should be measured against specific samples.
Question material comes from public community discussions. Configuration values are common starting points and should be measured against your own samples. Verified on 2026-09-21.